The Double-Edged Sword: Legumain as a Context-Dependent Mediator and Therapeutic Target in Cancer and Cardiovascular Disease
Cells · 2026
DOI: 10.3390/cells15181678 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Siarhei A Dabravolski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology Engineering, Braude Academic College of Engineering, Snunit 51, P.O. Box 78, Karmiel 2161002, Israel. Hauptthemen laut MEDLINE: Cysteine Endopeptidases, Neoplasms, Cardiovascular Diseases, Molecular Targeted Therapy. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Legumain, an asparaginyl endopeptidase, has emerged as a critical cysteine protease with diverse and complex roles in human health and disease. While traditionally known for its function in endolysosomal protein degradation, a growing body of evidence has revealed its presence in multiple cellular compartments and its involvement in a vast array of pathological processes. This review provides a comprehensive synthesis of the current literature, bridging the often-siloed research in oncology and cardiovascular medicine to present a unified view of legumain’s function. We first detail the multifaceted role of legumain in cancer, where it acts as a driver of tumour proliferation, invasion, and metastasis. We explore its function as a modulator of the tumour microenvironment, particularly its ability to polarise macrophages towards an immunosuppressive phenotype, and discuss its emerging value as a candidate prognostic biomarker and a versatile therapeutic target. Notably, however, therapeutic targeting of legumain remains predominantly at the preclinical stage. Subsequently, we examine its significant contribution to cardiovascular diseases, detailing its mechanistic involvement in promoting atherosclerosis, hypertension, and adverse cardiac remodelling through pathways involving inflammation, extracellular matrix turnover, and immune cell modulation. By synthesising these findings, we highlight the convergent pathological mechanisms, discuss current controversies and methodological limitations—such as the lack of standardised assays—and propose key future directions. This review frames legumain as a biological rheostat and a potentially important node in chronic disease, underscoring its potential as a powerful biomarker and a sophisticated therapeutic target across a broad spectrum of human pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology Engineering, Braude Academic College of Engineering, Snunit 51, P.O. Box 78, Karmiel 2161002, Israel.
- Smirnov Institute of Experimental Cardiology, Chazov National Medical Research Center of Cardiology, 15-A, Academician Chazov Street, 121552 Moscow, Russia.
- Laboratory of Molecular Genetic Modeling of Inflamaging, Institute of General Pathology and Pathophysiology, 8, Baltiiskaya Street, 125315 Moscow, Russia.
- Institute for Atherosclerosis Research, 4-1-207, Osennyaya Street, 121609 Moscow, Russia.
- Scientific and Educational Center for Molecular and Cellular Technologies, St. Petersburg Chemical Federal University, 21 Rentgen Street, 197101 St. Petersburg, Russia.
ORCID-Profile: Siarhei A Dabravolski, Gulalek A Babayeva, Daria D Borodko, Stanislav A Antonov
Förderung
- Russian Science Foundation
Zitieren
APA
Dabravolski, S. A., Babayeva, G. A., Borodko, D. D., Rozhkova, U. V., Antonov, S. A., Utkina, A. S., & Nerush, M. O. (2026). The Double-Edged Sword: Legumain as a Context-Dependent Mediator and Therapeutic Target in Cancer and Cardiovascular Disease. Cells. https://doi.org/10.3390/cells15181678
Vancouver
Dabravolski SA, Babayeva GA, Borodko DD, Rozhkova UV, Antonov SA, Utkina AS, et al. The Double-Edged Sword: Legumain as a Context-Dependent Mediator and Therapeutic Target in Cancer and Cardiovascular Disease. Cells. 2026. doi:10.3390/cells15181678
BibTeX
@article{Dabravolski2026,
author = {Dabravolski, Siarhei A and Babayeva, Gulalek A and Borodko, Daria D and Rozhkova, Ulyana V and Antonov, Stanislav A and Utkina, Aleksandra S and Nerush, Maria O},
title = {The Double-Edged Sword: Legumain as a Context-Dependent Mediator and Therapeutic Target in Cancer and Cardiovascular Disease},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15181678}
}
EUVIMED